NASDAQ · GILD

Gilead Sciences, Inc.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 +1
  • account_balance
    854 funds bought, 806 sold in the quarter ended Jun 30, 2026. 160 were new holders.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

2,283 funds report owning GILD, down from 2,326

Holdings as of Jun 30, 2026
New160
Added694
Held826
Trimmed603
Sold out203

Last quarter

Who bought and who sold

Change in shares held, biggest holdings first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

No open-market buys or sales by officers or directors in the last 12 months. Hidden: 3 option exercises, 5 planned 10b5-1 sales. Press All filings to see them.

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOption exercise · Oct 30 · $1.15MPlanned sale (10b5-1) · Oct 30 · $2.78MPlanned sale (10b5-1) · Nov 2 · $2.55MOption exercise · Nov 4 · $7.42MPlanned sale (10b5-1) · Nov 4 · $18MOption exercise · Nov 5 · $710KPlanned sale (10b5-1) · Nov 5 · $1.72MPlanned sale (10b5-1) · Nov 6 · $558K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOption exercise · Oct 30 · $1.15MPlanned sale (10b5-1) · Oct 30 · $2.78MPlanned sale (10b5-1) · Nov 2 · $2.55MOption exercise · Nov 4 · $7.42MPlanned sale (10b5-1) · Nov 4 · $18MOption exercise · Nov 5 · $710KPlanned sale (10b5-1) · Nov 5 · $1.72MPlanned sale (10b5-1) · Nov 6 · $558K

Last 6 months. A wider screen shows 12.

Showing 0 real trades. Hidden: 3 option exercises, 5 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Congress · last 12 months

Members of Congress who traded GILD

All Congress trades
GILD Gilead Sciences, Inc. - Common Stock Jared Moskowitz FL-23 · Child Purchase $1,001 – $15,000 Traded May 6, 2026 Reported Jun 19, 2026
GILD Gilead Sciences, Inc. - Common Stock Jared Moskowitz FL-23 Purchase $1,001 – $15,000 Traded May 6, 2026 Reported Jun 19, 2026
GILD Gilead Sciences, Inc. - Common Stock Alan Armstrong OK Purchase $1,001 – $15,000 Traded Mar 27, 2026 Reported Jul 21, 2026 · 116 days later
GILD Gilead Sciences, Inc. - Common Stock Josh Gottheimer NJ-5 · Joint Purchase $1,001 – $15,000 Traded Jan 27, 2026 Reported Feb 26, 2026

Amounts are the ranges members report, not exact amounts. Reports can come up to 45 days after the trade. From House and Senate STOCK Act reports. This is data, not advice.

Top holders

Biggest funds in GILD

As of Jun 30, 2026
FundValueChange
BlackRock, Inc.$15.4B+2%
Vanguard Capital Management LLC$10.2B+1%
FMR LLC$8.45B−7%
State Street Corp$7.73B+2%
Capital World Investors$5.18B−1%

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate.

This is data, not investment advice. About StockToast